Autopsy report · NCT04285268
Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Cause of deathSlow enrollment, also regulatory or ethics
“This study was never submitted to the IRB for review and approval. No research subjects were enrolled. .”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University, hospital or other
- Conditions
- High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
- Interventions
- Bortezomib; Rituximab; Venetoclax
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
“Study was never initiated. No IRB approval obtained, and no participants enrolled.” - Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
“The study was never initiated, no patients were enrolled. It has been closed with the IRB.” - Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients
“The study did not enroll participants and had not shown significant progress since the initial IRB approval.” - Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus
“IRB did not approve this study.” - Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
“Study did not receive IRB approval.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.